拓荊科技(688072.SH):子公司巖泉科技擬以2000萬元收購芯密科技1.5625%的股權
格隆匯5月31日丨拓荊科技(688072.SH)公佈,根據公司發展戰略規劃,為進一步增強上游供應鏈的穩定性及產業協同性,公司的全資子公司巖泉科技擬以人民幣2000萬元認繳芯密科技新增註冊資本人民幣78.7316萬元,獲得本次增資後芯密科技1.5625%的股權。
芯密科技是一家專注於高端密封材料與產品解決方案的高科技企業,致力於為半導體與顯示行業的刻蝕、薄膜、擴散等關鍵工藝設備提供高性能全氟密封圈與密封部件。目前芯密科技產品已通過多家半導體設備廠商的驗證,並廣泛應用於國內各大集成電路製造企業,在國內市場佔據領先地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.